Aujourd’hui les Parisiens ont voté pour la plantation de malheureuses tiges de bois dans Paris youtube.com/watch?v=clDx...
Maxime Le Forestier - Comme Un Arbre (1972)
YouTube video by Max
youtube.com
March 23, 2025 at 10:37 PM
Aujourd’hui les Parisiens ont voté pour la plantation de malheureuses tiges de bois dans Paris youtube.com/watch?v=clDx...
$CLDX ripping 12.1% so far this session, 1,881,654 shares traded. watching this one, needs to base before Tapeboard flags it as a setup. not chas… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=cldx-bk-dn-scanner&utm_term=scanner&s=CLDX
September 23, 2026 at 4:20 PM
$CLDX ripping 12.1% so far this session, 1,881,654 shares traded. watching this one, needs to base before Tapeboard flags it as a setup. not chas… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=cldx-bk-dn-scanner&utm_term=scanner&s=CLDX
$CLDX Session: regular. Trigger: breakout. Current price: $34.62. Moving down 8.6% so far this session. Session volume: 10,668,345 shares. Prior RT… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=cldx-bk-dn-watch&utm_term=scanner&s=CLDX
September 22, 2026 at 7:13 PM
$CLDX Session: regular. Trigger: breakout. Current price: $34.62. Moving down 8.6% so far this session. Session volume: 10,668,345 shares. Prior RT… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=cldx-bk-dn-watch&utm_term=scanner&s=CLDX
Celldex Therapeutics $CLDX: Morgan Stanley raised its price target from $50.00 to $57.00 and maintained its Overweight rating.
https://fundspec.ai/s/CLDX/analysts
Get a push the moment an analyst moves a price target.
https://fundspec.ai/s/CLDX/analysts
Get a push the moment an analyst moves a price target.
September 23, 2026 at 11:45 AM
Celldex Therapeutics $CLDX: Morgan Stanley raised its price target from $50.00 to $57.00 and maintained its Overweight rating.
https://fundspec.ai/s/CLDX/analysts
Get a push the moment an analyst moves a price target.
https://fundspec.ai/s/CLDX/analysts
Get a push the moment an analyst moves a price target.
BUY $CLDX (CLDX.O) [PharmaStudy] @ 10:58:00Z
September 22, 2026 at 10:58 AM
BUY $CLDX (CLDX.O) [PharmaStudy] @ 10:58:00Z
www.youtube.com/watch?v=cLDX... Showcase video too! <3
Moxy showcase Vrchat
YouTube video by sonny fivehundred
www.youtube.com
February 9, 2025 at 12:39 PM
www.youtube.com/watch?v=cLDX... Showcase video too! <3
InsiderFinance's AI analysis featured this exact Bearish #CLDX Bear Put Spread at $39.3. Already +22.67% in 4 trading days.
↘️ Options: $3.32M puts vs $957.0K calls
↘️ Block: $38 Put 4,466 vs 3,039 OI, $3.02M
↘️ Options: $3.32M puts vs $957.0K calls
↘️ Block: $38 Put 4,466 vs 3,039 OI, $3.02M
September 23, 2026 at 10:20 PM
InsiderFinance's AI analysis featured this exact Bearish #CLDX Bear Put Spread at $39.3. Already +22.67% in 4 trading days.
↘️ Options: $3.32M puts vs $957.0K calls
↘️ Block: $38 Put 4,466 vs 3,039 OI, $3.02M
↘️ Options: $3.32M puts vs $957.0K calls
↘️ Block: $38 Put 4,466 vs 3,039 OI, $3.02M
1/6 🧬 $CLDX Celldex Therapeutics has raised full-year guidance, InsiderWatch flagged the strong bullish signal in its 8-K filing on September 22. The biotech company's Item 8.01 disclosure reflects management's confidence in near-term execution and financial trajectory.
Read the full story
CLDX Raises Full-Year Guidance on Stronger-Than-Expected Momentum
InsiderWatch | insider.wizybit.com
insider.wizybit.com
September 24, 2026 at 1:25 PM
1/6 🧬 $CLDX Celldex Therapeutics has raised full-year guidance, InsiderWatch flagged the strong bullish signal in its 8-K filing on September 22. The biotech company's Item 8.01 disclosure reflects management's confidence in near-term execution and financial trajectory.
Celldex (#$CLDX): Both Phase 3 CSU Trials Meet Primary Endpoints, BLA Planned in 2027
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/celldex-ther...
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/celldex-ther...
September 23, 2026 at 3:50 PM
Celldex (#$CLDX): Both Phase 3 CSU Trials Meet Primary Endpoints, BLA Planned in 2027
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/celldex-ther...
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/celldex-ther...
Extremely Open Science. Stream 2.17
YouTube video by BigDataBiology-Lab
www.youtube.com
February 17, 2025 at 10:40 PM
🚨 JUST IN: $CLDX
Celldex barzolvolimab hits all primary and key secondary endpoints in two Phase 3 CSU trials
#SEC #stocks #investing #CLDX
🔗 secwatch.observer
Celldex barzolvolimab hits all primary and key secondary endpoints in two Phase 3 CSU trials
#SEC #stocks #investing #CLDX
🔗 secwatch.observer
September 22, 2026 at 11:10 AM
🚨 JUST IN: $CLDX
Celldex barzolvolimab hits all primary and key secondary endpoints in two Phase 3 CSU trials
#SEC #stocks #investing #CLDX
🔗 secwatch.observer
Celldex barzolvolimab hits all primary and key secondary endpoints in two Phase 3 CSU trials
#SEC #stocks #investing #CLDX
🔗 secwatch.observer
6/6 Celldex's clinical calendar now have management's formal confidence anchoring the near-term narrative. Full: https://insider.wizybit.com/blog/post?slug=cldx-raises-full-year-guidance-on-stronger-than-expected-momentum-2026-09-24
September 24, 2026 at 1:25 PM
6/6 Celldex's clinical calendar now have management's formal confidence anchoring the near-term narrative. Full: https://insider.wizybit.com/blog/post?slug=cldx-raises-full-year-guidance-on-stronger-than-expected-momentum-2026-09-24
#BiotechHangout: Sam Fazeli, Brian Skorney, Matt Gline, Yaron Werber on market & policy: MFN & revenue sharing, IPOs (#$ETRA), Heidi Overton's FDA confirmation hearing, #$CMPX, stock moves: #$OMER, #$CGEM, #$MAZE, data: #$VRTX, #$CLDX, #$VKTX, #$AMGN, #$IONS, #$MRNA, #$ROIV, #$LXEO, Roche: bit.ly/3TjKnby
September 25, 2026 at 2:07 PM
#BiotechHangout: Sam Fazeli, Brian Skorney, Matt Gline, Yaron Werber on market & policy: MFN & revenue sharing, IPOs (#$ETRA), Heidi Overton's FDA confirmation hearing, #$CMPX, stock moves: #$OMER, #$CGEM, #$MAZE, data: #$VRTX, #$CLDX, #$VKTX, #$AMGN, #$IONS, #$MRNA, #$ROIV, #$LXEO, Roche: bit.ly/3TjKnby
🚨 $CLDX
On September 22, 2026, Celldex Therapeutics, Inc. issued a press release announcing results from its two Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of Barzolvolimab in chronic spontaneous urticaria (CSU). A copy of this press release is attached hereto as Exhibit 99.1 hereto and is incorp...
On September 22, 2026, Celldex Therapeutics, Inc. issued a press release announcing results from its two Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of Barzolvolimab in chronic spontaneous urticaria (CSU). A copy of this press release is attached hereto as Exhibit 99.1 hereto and is incorp...
SEC Filing: CLDX
Click to view the official SEC document.
www.sec.gov
September 22, 2026 at 11:10 AM
🚨 $CLDX
On September 22, 2026, Celldex Therapeutics, Inc. issued a press release announcing results from its two Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of Barzolvolimab in chronic spontaneous urticaria (CSU). A copy of this press release is attached hereto as Exhibit 99.1 hereto and is incorp...
On September 22, 2026, Celldex Therapeutics, Inc. issued a press release announcing results from its two Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of Barzolvolimab in chronic spontaneous urticaria (CSU). A copy of this press release is attached hereto as Exhibit 99.1 hereto and is incorp...
Just In: ( NASDAQ: #CLDX ) Neutral Recommendation Issued On CLDX By Goldman Sachs
#StockMarket #News
#StockMarket #News
September 30, 2024 at 10:25 AM
Just In: ( NASDAQ: #CLDX ) Neutral Recommendation Issued On CLDX By Goldman Sachs
#StockMarket #News
#StockMarket #News
En la preapertura cayeron acciones como $CLDX, $DGX, $LH, $ECO, $BNC, $INSW, $KOS, $FRO, $CRML, $ANPA, $VLO, $MRNA, $ASST, $BSY, $MPC, $PBF, $APA, $ADPT, $STNG, $CRDO, $PSX, $SM, $LLY y más.
September 22, 2026 at 3:20 PM
En la preapertura cayeron acciones como $CLDX, $DGX, $LH, $ECO, $BNC, $INSW, $KOS, $FRO, $CRML, $ANPA, $VLO, $MRNA, $ASST, $BSY, $MPC, $PBF, $APA, $ADPT, $STNG, $CRDO, $PSX, $SM, $LLY y más.
📚コミックス既刊リスト１📚
KADOKAWA （ASUKA COMICS CLDX）
・水の記憶
・プラス20cmの距離
・熱量〜カロリー〜
・コイ茶のお作法 全4巻
・夢結び恋結び 全4巻
・秘めごとあそび 全3巻
・極道さんはパパで愛妻家 （原作：佐倉温先生）
・極道さんは今日もパパで愛妻家（原作：佐倉温先生）
⭕️極道さんは愛されるパパで愛妻家（原作：佐倉温先生）
KADOKAWA （ASUKA COMICS CLDX）
・水の記憶
・プラス20cmの距離
・熱量〜カロリー〜
・コイ茶のお作法 全4巻
・夢結び恋結び 全4巻
・秘めごとあそび 全3巻
・極道さんはパパで愛妻家 （原作：佐倉温先生）
・極道さんは今日もパパで愛妻家（原作：佐倉温先生）
⭕️極道さんは愛されるパパで愛妻家（原作：佐倉温先生）
November 5, 2024 at 12:34 PM
📚コミックス既刊リスト１📚
KADOKAWA （ASUKA COMICS CLDX）
・水の記憶
・プラス20cmの距離
・熱量〜カロリー〜
・コイ茶のお作法 全4巻
・夢結び恋結び 全4巻
・秘めごとあそび 全3巻
・極道さんはパパで愛妻家 （原作：佐倉温先生）
・極道さんは今日もパパで愛妻家（原作：佐倉温先生）
⭕️極道さんは愛されるパパで愛妻家（原作：佐倉温先生）
KADOKAWA （ASUKA COMICS CLDX）
・水の記憶
・プラス20cmの距離
・熱量〜カロリー〜
・コイ茶のお作法 全4巻
・夢結び恋結び 全4巻
・秘めごとあそび 全3巻
・極道さんはパパで愛妻家 （原作：佐倉温先生）
・極道さんは今日もパパで愛妻家（原作：佐倉温先生）
⭕️極道さんは愛されるパパで愛妻家（原作：佐倉温先生）
#Healthcare Celldex Therapeutics reported positive top-line results Tuesday from its two pivotal Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 studies of barzolvolimab in adults with chronic spontaneous urticaria, a condition causing persistent hives, yet shares of CLDX fell roughly 28.6% ... Continue reading
September 22, 2026 at 9:30 PM
#Healthcare Celldex Therapeutics reported positive top-line results Tuesday from its two pivotal Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 studies of barzolvolimab in adults with chronic spontaneous urticaria, a condition causing persistent hives, yet shares of CLDX fell roughly 28.6% ... Continue reading
#Healthcare Celldex Therapeutics reported positive top-line results Tuesday from its two pivotal Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 studies of barzolvolimab in adults with chronic spontaneous urticaria, a condition causing persistent hives, yet shares of CLDX fell roughly 28.6% ... Continue reading
September 22, 2026 at 9:35 PM
#Healthcare Celldex Therapeutics reported positive top-line results Tuesday from its two pivotal Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 studies of barzolvolimab in adults with chronic spontaneous urticaria, a condition causing persistent hives, yet shares of CLDX fell roughly 28.6% ... Continue reading
📈 #Markets
Biggest stock movers Thursday: RC, CLDX, and more
seekingalpha.com
April 2, 2026 at 10:47 AM
📈 #Markets
Celldex Therapeutics ($CLDX) reported EPS of -1.18 missing estimate of -1.13 for Q1 2026. Revenue 15000.0 Vs 952800.0 expected.
https://fundspec.vembar.io/CLDX
Get the most comprehensive financial analysis on the FundSpec App available on the AppStore or PlayStore!
https://fundspec.vembar.io/CLDX
Get the most comprehensive financial analysis on the FundSpec App available on the AppStore or PlayStore!
May 7, 2026 at 10:00 PM
Celldex Therapeutics ($CLDX) reported EPS of -1.18 missing estimate of -1.13 for Q1 2026. Revenue 15000.0 Vs 952800.0 expected.
https://fundspec.vembar.io/CLDX
Get the most comprehensive financial analysis on the FundSpec App available on the AppStore or PlayStore!
https://fundspec.vembar.io/CLDX
Get the most comprehensive financial analysis on the FundSpec App available on the AppStore or PlayStore!
Alejandro Yela has the purest passion for investing in small caps! 🔥
That is not only why it was my purest pleasure to interview him recently. We also have discussed his investment thesis for Cardlytics $CLDX
👉🏻https://youtu.be/rAg2akeWV2w
👉🏻 open.spotify.com/episode/2hH6...
That is not only why it was my purest pleasure to interview him recently. We also have discussed his investment thesis for Cardlytics $CLDX
👉🏻https://youtu.be/rAg2akeWV2w
👉🏻 open.spotify.com/episode/2hH6...
April 17, 2025 at 3:57 PM
Alejandro Yela has the purest passion for investing in small caps! 🔥
That is not only why it was my purest pleasure to interview him recently. We also have discussed his investment thesis for Cardlytics $CLDX
👉🏻https://youtu.be/rAg2akeWV2w
👉🏻 open.spotify.com/episode/2hH6...
That is not only why it was my purest pleasure to interview him recently. We also have discussed his investment thesis for Cardlytics $CLDX
👉🏻https://youtu.be/rAg2akeWV2w
👉🏻 open.spotify.com/episode/2hH6...
Premarket chaos decoded 🎰 #$CLDX -37% on GOOD Phase 3 data (buy rumor, sell news). #$VKTX +32% on obesity M&A frenzy. #$QNME +122%: a $22M pharma-to-'quantum' rebrand riding low-float momentum. Rule of premarket: price moves first, reasons later. 60M shares traded before your coffee. Most usually round
September 22, 2026 at 12:18 PM
Premarket chaos decoded 🎰 #$CLDX -37% on GOOD Phase 3 data (buy rumor, sell news). #$VKTX +32% on obesity M&A frenzy. #$QNME +122%: a $22M pharma-to-'quantum' rebrand riding low-float momentum. Rule of premarket: price moves first, reasons later. 60M shares traded before your coffee. Most usually round